Skip to main content
Top
Published in: European Spine Journal 10/2013

01-10-2013 | Author's Reply

Answer to the Letter to the Editor of H. Namazi concerning “Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts” by Lange T, Stehling C, Fröhlich B, Klingenhöfer M, Kunkel P, Schneppenheim R, Escherich G, Gosheger G, Hardes J, Jürgens H, Schulte TL (2013), Eur Spine J;22(6):1417–1422

Authors: T. Lange, T. L. Schulte

Published in: European Spine Journal | Issue 10/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Gatti D, Viapiana O, Fracassi E, Idolazzi L, Dartizio C, Povino MR et al (2012) Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab. J Bone Miner Res 27(11):2259–2263PubMedCrossRef Gatti D, Viapiana O, Fracassi E, Idolazzi L, Dartizio C, Povino MR et al (2012) Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab. J Bone Miner Res 27(11):2259–2263PubMedCrossRef
2.
go back to reference Lange T, Stehling C, Fröhlich B, Klingenhöfer M, Kunkel P, Schneppenheim R, Escherich G, Gosheger G, Hardes J, Jürgens H, Schulte TL (2013) Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts. Eur Spine J 22(6):1417–1422PubMedCrossRef Lange T, Stehling C, Fröhlich B, Klingenhöfer M, Kunkel P, Schneppenheim R, Escherich G, Gosheger G, Hardes J, Jürgens H, Schulte TL (2013) Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts. Eur Spine J 22(6):1417–1422PubMedCrossRef
3.
go back to reference Baron R, Rawadi G (2007) Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148:2635–2643PubMedCrossRef Baron R, Rawadi G (2007) Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148:2635–2643PubMedCrossRef
4.
go back to reference Gatti D, Viapiana O, Idolazzi L, Fracassi E, Rossini M, Adami S (2011) The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1. J Clin Endocrinol Metab 96(5):1555–1559PubMedCrossRef Gatti D, Viapiana O, Idolazzi L, Fracassi E, Rossini M, Adami S (2011) The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1. J Clin Endocrinol Metab 96(5):1555–1559PubMedCrossRef
Metadata
Title
Answer to the Letter to the Editor of H. Namazi concerning “Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts” by Lange T, Stehling C, Fröhlich B, Klingenhöfer M, Kunkel P, Schneppenheim R, Escherich G, Gosheger G, Hardes J, Jürgens H, Schulte TL (2013), Eur Spine J;22(6):1417–1422
Authors
T. Lange
T. L. Schulte
Publication date
01-10-2013
Publisher
Springer Berlin Heidelberg
Published in
European Spine Journal / Issue 10/2013
Print ISSN: 0940-6719
Electronic ISSN: 1432-0932
DOI
https://doi.org/10.1007/s00586-013-2956-5

Other articles of this Issue 10/2013

European Spine Journal 10/2013 Go to the issue